Adjunctive Ziprasidone in the Treatment of Bipolar I Depression
Public ClinicalTrials.gov record NCT00483548. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Six-Week, Double-Blind, Multicenter, Placebo Controlled Study Evaluating The Efficacy And Safety Of Flexible Doses Of Oral Ziprasidone As Add-On, Adjunctive Therapy With Lithium, Valproate Or Lamotrigine In Bipolar I Depression
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine if a treatment regimen of ziprasidone plus a mood stabilizer is safe and effective in the short term treatment of Bipolar I Depression. Ziprasidone will be added to lithium, valproate or lamotrigine after the patient has been on a therapeutic dose of one of these mood stabilizers for at least 4 weeks.
Study identification
- NCT ID
- NCT00483548
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 298 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2007 (Type not available)
- Primary completion
- Dec 2008 (Actual)
- Completion
- Dec 2008 (Actual)
- Last update posted
- Mar 10, 2021
2007 – 2008
United States locations
- U.S. sites
- 60
- U.S. states
- 26
- U.S. cities
- 53
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Chandler | Arizona | 85226 | — |
| Pfizer Investigational Site | Litchfield Park | Arizona | 85340 | — |
| Pfizer Investigational Site | Little Rock | Arkansas | 72211 | — |
| Pfizer Investigational Site | Little Rock | Arkansas | 72223 | — |
| Pfizer Investigational Site | Springdale | Arkansas | 72762 | — |
| Pfizer Investigational Site | Costa Mesa | California | 92627 | — |
| Pfizer Investigational Site | Oceanside | California | 92056 | — |
| Pfizer Investigational Site | San Diego | California | 92108 | — |
| Pfizer Investigational Site | Torrance | California | 90502 | — |
| Pfizer Investigational Site | Boca Raton | Florida | 33486-1340 | — |
| Pfizer Investigational Site | Boca Raton | Florida | 33486 | — |
| Pfizer Investigational Site | Jacksonville | Florida | 32256-2006 | — |
| Pfizer Investigational Site | Orlando | Florida | 32806 | — |
| Pfizer Investigational Site | Sanford | Florida | 32771 | — |
| Pfizer Investigational Site | St. Petersburg | Florida | 33702 | — |
| Pfizer Investigational Site | West Palm Beach | Florida | 33407 | — |
| Pfizer Investigational Site | Chicago | Illinois | 60640 | — |
| Pfizer Investigational Site | Skokie | Illinois | 60077 | — |
| Pfizer Investigational Site | Greenwood | Indiana | 46143 | — |
| Pfizer Investigational Site | Indianapolis | Indiana | 46260 | — |
| Pfizer Investigational Site | Topeka | Kansas | 66606 | — |
| Pfizer Investigational Site | Wichita | Kansas | 67207 | — |
| Pfizer Investigational Site | Lake Charles | Louisiana | 70601 | — |
| Pfizer Investigational Site | Rockville | Maryland | 20852 | — |
| Pfizer Investigational Site | Boston | Massachusetts | 02135 | — |
| Pfizer Investigational Site | Watertown | Massachusetts | 02472 | — |
| Pfizer Investigational Site | Clinton Township | Michigan | 48038 | — |
| Pfizer Investigational Site | Saint Charles | Missouri | 63301 | — |
| Pfizer Investigational Site | St Louis | Missouri | 63044-2588 | — |
| Pfizer Investigational Site | Lincoln | Nebraska | 68510 | — |
| Pfizer Investigational Site | Nashua | New Hampshire | 03060 | — |
| Pfizer Investigational Site | Cherry Hill | New Jersey | 08002 | — |
| Pfizer Investigational Site | Clementon | New Jersey | 08021 | — |
| Pfizer Investigational Site | Brooklyn | New York | 11201 | — |
| Pfizer Investigational Site | Glen Oaks | New York | 11004 | — |
| Pfizer Investigational Site | New York | New York | 10023 | — |
| Pfizer Investigational Site | Olean | New York | 14760 | — |
| Pfizer Investigational Site | Rochester | New York | 14618 | — |
| Pfizer Investigational Site | Staten Island | New York | 10312 | — |
| Pfizer Investigational Site | Chapel Hill | North Carolina | 27599 | — |
| Pfizer Investigational Site | Cincinnati | Ohio | 45227 | — |
| Pfizer Investigational Site | Cincinnati | Ohio | 45267-0516 | — |
| Pfizer Investigational Site | Columbus | Ohio | 43210 | — |
| Pfizer Investigational Site | Dayton | Ohio | 45408 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73116 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73119 | — |
| Pfizer Investigational Site | Portland | Oregon | 97210 | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | 19104 | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | 19139 | — |
| Pfizer Investigational Site | Memphis | Tennessee | 38117 | — |
| Pfizer Investigational Site | Austin | Texas | 78754 | — |
| Pfizer Investigational Site | Austin | Texas | 78756 | — |
| Pfizer Investigational Site | Houston | Texas | 77040 | — |
| Pfizer Investigational Site | Houston | Texas | 77074 | — |
| Pfizer Investigational Site | Lake Jackson | Texas | 77566 | — |
| Pfizer Investigational Site | Charlottesville | Virginia | 22903 | — |
| Pfizer Investigational Site | Kirkland | Washington | 98033 | — |
| Pfizer Investigational Site | Richland | Washington | 99352 | — |
| Pfizer Investigational Site | Seattle | Washington | 98104 | — |
| Pfizer Investigational Site | Brown Deer | Wisconsin | 53223 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00483548, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 10, 2021 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00483548 live on ClinicalTrials.gov.